• Print

Strong sales, record profitability and cash flow

Compared to the high base in the first half of 2020, order intake remained stable (0.2% increase), while it decreased 3.3% organically due to the anticipated drop in Energy. Sales increased by a significant 9.2% (6.1% organically) which contributed to a record high operational profitability of 10.0%. Besides higher volumes, additional CHF 23 million of savings from structural actions also helped to achieve this result. Free cash flow reached CHF 117.1 million, a jump of CHF 80.3 million compared with last year.

Note: If not otherwise indicated, changes from the previous year are based on currency-adjusted figures. Sulzer uses some alternative performance measures, these are defined in the Sulzer Annual Report 2020.

Stable order intake and positive mix effect

Thanks to continued sequential order intake growth, Sulzer’s order intake remained stable (0.2% increase) in the first half of 2021, totaling CHF 1’820.4 million – despite a high comparable base in 2020. Acquisitions contributed CHF 67.4 million to order intake. Currency translation effects had a negative impact on order intake of CHF 24.0 million. Order intake gross margin increased to 35.3%, well up from 33.3% in H1 2020 on the back of a better mix.

In the first half of 2021, Sulzer achieved robust sequential growth in order intake. Thanks to swift structural actions to mitigate the drop in Energy, as well as solid execution, we have surpassed pre-pandemic levels of profitability and cash flow generation.

Jill Lee, Chief Financial Officer

Order intake growth in Water and Industry within Pumps Equipment could only partially offset the anticipated drop in Energy, leading to a decrease of 15.3% (–20.2% organically) in the division. Water orders increased by 25.2%, including 7.0% organic growth and CHF 39.4 million from the Nordic Water acquisition. Industry also saw a strong first half-year, with orders up 5.8%. Due to the anticipated drop in demand and continued order selectivity, the Energy segment declined by 49.5%. Compared to the record high first half of 2020, the Rotating Equipment Services division recorded an order intake decline of 5.6%. In Q2 2021, the division saw the highest quarterly order intake since Q1 2020, emphasizing the positive sequential momentum in all regions as customers begin to ease site access restrictions. Chemtech’s order intake increased by 12.8%, driven by increases in the US and China, as well as the growing Renewables segment. In the Applicator Systems division, orders reached a record level of CHF 268.9 million on the back of a strong market rebound. The Haselmeier acquisition contributed CHF 25.5 million. Compared to the prior year, orders increased by 69.4% or 53.3% organically.

We enter the second half of 2021 with a high order backlog of CHF 1’948.9 million (December 31, 2020: CHF 1’758.9 million). Positive currency translation effects totaled CHF 31.1 million.

Orders

millions of CHF

 

2021

 

2020

Order intake

 

1’820.4

 

1’840.5

Order intake gross margin

 

35.3%

 

33.3%

Order backlog as of June 30/ December 31

 

1’948.9

 

1’758.9

Sales rebound in all divisions

Sales increased by 9.2% compared to the first half of 2020, reaching CHF 1’723.3 million. Organic growth was 6.1% with acquisitions adding CHF 52.1 million, while negative currency translation effects amounted to CHF 22.3 million.

The Pumps Equipment division increased its sales by 8.8% (4.4% organically). Taking into account the successful Nordic Water acquisition, sales in Water increased by 23.7% and 9.3% organically. Along with 12.6% higher sales in Industry, the sales decline in Energy (–4.7%) was more than offset. Sales in Rotating Equipment Services grew in all regions with the continued easing of customer site restrictions, reaching an increase of 1.3% year-on-year. In Chemtech, sales were up by 7.7% thanks to strong execution in China and a reduced impact from lockdowns compared to last year. Sales in Applicator Systems rebounded strongly with 38.4% growth. The Haselmeier acquisition contributed CHF 21.3 million. Healthcare now represents 38.5% of the division’s sales.

Higher gross profit margin on volume and mix

Gross profit margin increased to 31.2% in the first half of 2021 (2020: 29.8%), thanks to higher sales volume, a larger share of high-margin business and positive impact from implemented cost actions, resulting in an increased gross profit of CHF 538.5 million (first half of 2020: CHF 476.0 million).

Operational profitability at 10%

Operational profit amounted to CHF 171.6 million compared with CHF 120.2 million in the first half of 2020, an increase of 43.5%. The higher gross profit from increased sales and a better mix was further supported by CHF 23 million savings from cost reduction measures in the Energy-related business and continued spending discipline.

Operational profitability reached a record H1 high of 10.0%, compared with 7.5% in H1 2020.

Bridge from EBIT to operational profit (January 1 – June 30)

millions of CHF

 

2021

 

2020

Operating income (EBIT)

 

128.7

 

36.0

Amortization

 

35.7

 

31.6

Impairments on tangible and intangible assets

 

0.9

 

4.2

Restructuring expenses

 

2.0

 

42.0

Non-operational items 1)

 

4.3

 

6.4

Operational profit

 

171.6

 

120.2

1) Non-operational items include significant acquisition-related expenses, gains and losses from sale of businesses or real estate (including release of provisions), and certain non-operational items that are non-recurring or do not regularly occur in similar magnitude.

ROS and operational profitability (January 1 – June 30)

millions of CHF

 

2021

 

2020

Operating income (EBIT)

 

128.7

 

36.0

Sales

 

1’723.3

 

1’598.5

Return on sales (ROS)

 

7.5%

 

2.3%

 

 

 

 

 

Operational profit

 

171.6

 

120.2

Sales

 

1’723.3

 

1’598.5

Operational profitability

 

10.0%

 

7.5%

Return on sales of 7.5%

One-off expenses in the first half of 2021 amounted to CHF 7.2 million, compared to CHF 52.6 million in H1 2020. The expenses relate to the structural actions to adapt Sulzer’s Energy-related activities, initiated in the first half of 2020.

EBIT amounted to CHF 128.7 million, compared with CHF 36.0 million in the first half of 2020. Return on sales (ROS) was 7.5% compared with 2.3% in the same period of 2020.

Financial expenses

Total financial expenses amounted to CHF 13.4 million, compared with CHF 12.3 million in the first half of 2020. The majority of the increase is due to higher interest on borrowings.

Lower effective tax rate

Income tax expenses increased to CHF 27.9 million (2020: CHF 6.7 million) mainly due to higher pre-tax income. The effective tax rate for the first half of 2021 decreased to 24.4% compared with 28.4% in the first half of 2020, due to lower restructuring expenses with no corresponding tax effects and a more favorable allocation of profitability among the group’s entities.

Higher core net income

Net income increased to CHF 86.3 million compared with CHF 16.8 million in the previous year. Core net income, which excludes restructuring expenses, amortization, impairments, non-operational items and the tax-adjusted effects of non-operational items, totaled CHF 119.3 million, compared with CHF 81.5 million in the first half of 2020. Basic earnings per share increased from CHF 0.45 in the first half of 2020 to CHF 2.53 in the first half of 2021, primarily due to higher net income.

Bridge from net income to core net income

millions of CHF

 

2021

 

2020

Net income

 

86.3

 

16.8

Amortization

 

35.7

 

31.6

Impairments on tangible and intangible assets

 

0.9

 

4.2

Restructuring expenses

 

2.0

 

42.0

Non-operational items 1)

 

4.3

 

6.4

Tax impact on above items

 

–9.9

 

–19.4

Core net income

 

119.3

 

81.5

1) Other non-operational items include significant acquisition-related expenses, gains and losses from sale of businesses or real estate (including release of provisions), and certain non-operational items that are non-recurring or do not regularly occur in similar magnitude.

Key balance sheet positions

If not otherwise indicated, balance sheet movements from the previous year are based on nominal figures.

Total assets as of June 30, 2021, amounted to CHF 5’603.9 million, an increase of CHF 239.1 million from December 31, 2020. Non-current assets increased by CHF 188.7 million to CHF 2’390.7 million, mainly because of higher goodwill (CHF 76.5 million, due to CHF 53.8 million from new acquisitions and FX impact), higher other intangible assets (CHF 60.1 million) and higher property, plant and equipment (CHF 20.5 million). Current assets increased by CHF 50.5 million. Cash and cash equivalents increased by CHF 169.3 million. Current financial assets, comprised of fixed-term deposits with maturity dates between 3 and 12 months, decreased by CHF 302.2 million. The higher sales volume led to increases in inventories (CHF 67.1 million), contract assets (CHF 54.4 million) and supplier advances (CHF 16.5 million). Trade accounts receivables decreased (CHF 24.1 million), whereas other current receivables and prepaid expenses increased by CHF 74.8 million, mainly due to higher pension overfunding in Switzerland.

Total liabilities increased by CHF 187.1 million to CHF 4’134.7 million as of June 30, 2021. The main reasons were increases in undistributed dividends (CHF 43.5 million), other current liabilities (CHF 58.1 million), and contract liabilities (CHF 45.8 million) due to higher project-business sales and deferred income tax liabilities (CHF 38.8 million).

Equity increased by CHF 52.1 million to CHF 1’469.3 million. This was mainly driven by net income (CHF 86.3 million), currency translation effects (CHF 75.1 million) and the remeasurement of defined benefit obligations (CHF 55.6 million). These were offset by dividend distribution (CHF 137.5 million, of which CHF 2.1 million for non-controlling interests), and the acquisition of non-controlling interests (CHF 17.3 million).

Record free cash flow generation

Free cash flow amounted to CHF 117.1 million in the first half of 2021, a significant improvement compared to CHF 36.8 million reported in the same period last year, driven by higher net income and improved working capital efficiency.

Bridge from cash flow from operating activities to free cash flow (FCF)

millions of CHF

 

2021

 

2020

Cash flow from operating activities

 

155.1

 

91.8

Purchase of intangible assets

 

–4.0

 

–5.4

Sale of intangible assets

 

0.0

 

0.0

Purchase of property, plant and equipment

 

–38.9

 

–54.3

Sale of property, plant and equipment

 

4.9

 

4.7

Free cash flow (FCF)

 

117.1

 

36.8

Cash flow from investing activities totaled CHF 129.1 million, compared with CHF –17.3 million in the first half of 2020. In the first half of 2021, cash flow from investing activities was influenced by CHF 38.9 million for purchases of property, plant and equipment, CHF 130.8 million related to investment in subsidiaries and associates, mostly related to the acquisition of Nordic Water, and CHF 302.5 million from net change in financial assets.

Cash flow from financing activities totaled CHF –149.7 million compared with CHF –120.6 million in the first half of 2020, mainly due to the acquisition of non-controlling interests of CHF 17.3 million. In 2021, dividend payments amounted to CHF 91.9 million, compared with CHF 92.6 million in 2020. The net change in cash since January 1, 2021, amounted to CHF 169.3 million, including exchange gains on cash and cash equivalents of CHF 34.9 million.

Outlook for 2021

The positive trend in order intake continued in Q2, with all divisions again seeing sequential growth. While Q3 is likely to be seasonally lower, we expect it to show a strong improvement compared to the previous year, driven by continued growth in Applicator Systems and Chemtech, along with re-accelerating activities in Rotating Equipment Services and sustained growth in Water and Industry in Pumps Equipment.

Sulzer confirms its guidance that was updated on its Capital Markets Day in mid-June: For the full year 2021, Sulzer expects orders to increase by 4–6%1, sales to be up 8–10%1 and an operational profitability in the range of 10.0–10.5%.

Without medmix, Sulzer expects 2021 orders to be up 2–3%1 and sales up 6–8%1. Operational profitability is expected to be around 9%, above prepandemic levels.

1 Adjusted for FX and including acquisitions already closed.